These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 29607978

  • 1. The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.
    Hasegawa E, Ito S, Takai C, Kobayashi D, Nomura Y, Otani H, Abe A, Ishikawa H, Murasawa A, Narita I, Nakazono K.
    Intern Med; 2018 Aug 01; 57(15):2169-2178. PubMed ID: 29607978
    [Abstract] [Full Text] [Related]

  • 2. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial.
    Tamechika SY, Sasaki K, Hayami Y, Ohmura SI, Maeda S, Iwagaitsu S, Naniwa T.
    Arch Osteoporos; 2018 Jun 13; 13(1):67. PubMed ID: 29904824
    [Abstract] [Full Text] [Related]

  • 3. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
    Nakatoh S.
    J Bone Miner Metab; 2018 Mar 13; 36(2):221-228. PubMed ID: 28293779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Initiation of Monthly Minodronate Therapy at an Early Stage After Hip Fracture.
    Ohishi T, Fujita T, Suzuki D, Nishida T, Okabayashi R, Yamamoto K, Ushirozako H, Banno T, Matsuyama Y.
    J Clin Densitom; 2016 Mar 13; 19(3):352-8. PubMed ID: 27067298
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
    Ebina K, Noguchi T, Hirao M, Hashimoto J, Kaneshiro S, Yukioka M, Yoshikawa H.
    Osteoporos Int; 2016 Jan 13; 27(1):351-9. PubMed ID: 26475289
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis.
    Okazaki R, Hagino H, Ito M, Sone T, Nakamura T, Mizunuma H, Fukunaga M, Shiraki M, Nishizawa Y, Ohashi Y, Matsumoto T.
    Osteoporos Int; 2012 Jun 13; 23(6):1737-45. PubMed ID: 21932114
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment.
    Iba K, Sonoda T, Takada J, Dohke T, Yamashita T.
    J Bone Miner Metab; 2017 Mar 13; 35(2):171-176. PubMed ID: 26832388
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of minodronic acid for the prevention of osteoporosis in premenopausal women with gynaecologic disease who undergo bilateral oophorectomy: a single-centre, non-randomised controlled, experimental study.
    Okumura A, Kondo E, Kubo-Kaneda M, Yoshida K, Ikeda T.
    J Obstet Gynaecol; 2022 Nov 13; 42(8):3591-3599. PubMed ID: 36200398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.